The study confirmed FOXO4-DRI was effective across senescent cells generated by different methods (irradiation, doxorubicin, and replication stress), and documented that pre-treatment with FOXO4-DRI attenuated the dedifferentiation of chondrocytes during in vitro expansion establishing it as a valuable tool for research into senescent cell biology in cartilage and musculoskeletal models
The only data we have on BPC-157 being used in humans comes from a handful of small clinical trials, as such, finding a proper dosage can be difficult
The people who experience them are nearly always making the same mistake: too much, too soon
Human clinical trials have not been completed, meaning efficacy and safety in people is not established through rigorous research
Yes, Dihexa is particularly effective in addressing age-related cognitive decline by supporting brain plasticity and restoring cognitive functions that may have diminished over time
From an athletes perspective, I also wont consider using it until it has been approved by anti-doping authorities